Additionally, we excluded patients who had taken glucocorticoids, erythropoietin, or human granulocyte colony stimulating factor, patients who recently underwent blood donation or transfusion or patients with hematological diseases or autoimmune diseases to prevent the effect or routine changes in blood. This evidence concerns the gene EPO and hematologic disorder.